Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pacritinib and Clarithromycin Drug Interaction Study
NCT02807051Phase 1Completed
- Sponsor
- CTI BioPharma Corp.
- Start
- Sep 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pacritinib in myelofibrosis (MF), sponsored by CTI BioPharma Corp. Primary endpoint: Ratios of geometric mean values for pacritinib treatments with and without clarithromycin at 15 days. Started Sep 2014; status: completed.
02
Drugs
pacritinib
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT02807051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02807051.